Update December 13, 2014- CBS’ Dr. Lapook began investigating a similar Actavis business move as the one we first reported on in 2009, below. He looked into how the company removed from the market the drug Namenda, which will lose patent protection soon, forcing patients to instead buy the much more expensive Namenda XR that […]
↧